All News

Beta-blockers could be used as a potential treatment for COVID-19, according to a study by Italian and Australian researchers.

Further, the findings suggest that cancer survivors are also likely to be at an increased risk of severe coronavirus disease 2019 (COVID-19) outcomes, given that both influenza and COVID-19 are both epidemic respiratory viruses.

Compared with patients with focal epilepsy, those with genialized epilepsy have a higher risk of obstructive sleep apnea.

FDA grants fast track designation to irinotecan liposome injection (Onivyde; MM-398) as second-line monotherapy for patients with small cell lung cancer whose disease progressed following a platinum-based chemotherapy regimen.

Warning letters requested that companies immediately stop selling these unapproved products and said consumers concerned about COVID-19 should talk to their health care provider.

Xolair provides an alternative to surgery or steroids for the treatment of nasal polyps in adults.

Pharmacists must demonstrate value to achieve success when implementing new services and especially when establishing an entirely new practice.

COVID-19 has not stolen my final year of pharmacy school from me, but rather, has given me once in lifetime learning opportunities unique to this time in my life and in the world.

Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about the importance of preparing pharmacists and students to vaccinate the general public with the COVID-19 vaccine.

The COVID-19 mRNA vaccine, BNT162b2, developed by Pfizer and BioNTech, has been granted a temporary authorization for emergency use against COVID-19 in the United Kingdom.

Investigators hope discovery will lead to new treatments for pancreatic cancer.

A recently published meta-analysis by the UConn Institute for Collaboration on Health, Intervention, and Policy (InCHIP) is the first-ever to explore the use of yoga, meditation, and mindfulness-based interventions for the effective treatment of chronic concussion symptoms.

The connection between COVID-19 and sleep apnea cannot be explained by obesity rates alone.

Pralsetinib (Gavreto) approved for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer.

Medicaid expansion has helped to increase annual checkups among low income individuals.

Medicaid expansion was associated with a 2% drop in cancer mortality, a recent study found.

In an interview with Pharmacy Times, Peter Bonis, MD, said pharmacists are instrumental in making sure that patients receive drugs that are both safe and effective.

Are you curious about what other pharmacists earn? About the job satisfaction and compensation of pharmacists in other geographic areas? So are we!

The combination of COVID-19 with opioid-induced respiratory depression, especially in an elderly patient, could be deadly.

In the digital age, exponential technologies are converging and transforming how we engage in health care.

Device uses an Apple Watch to deliver gentle vibrations to users suffering from post-traumatic stress disorder.

Researchers found that COVID-19 severity was linked to cardiovascular risk factors, such as obesity, high blood pressure, diabetes, and high cholesterol.

The FDA has granted a breakthrough therapy designation to zanidatamab for the treatment of patients with HER2 gene–amplified biliary tract cancer who have received prior therapy.

Camber Pharmaceuticals is pleased to announce that it has launched Hydromorphone ER tablets, which is the generic version of Exalgo.

The new optical sensing method is based on multi-pass spectroscopy and can detect the presence of 1 molecule of formaldehyde in a million air particles, or 1 part per million, even in the presence of gasses that often interfere with optical measurements.

Students answer the question: How have campus groups or pharmacy organizations remained active during the pandemic?

Even when all 5 factors were optimally controlled, patients with type 2 diabetes still had a 21% higher risk for CVD and a 31% higher risk for heart failure hospitalization compared to patients without diabetes.

Pharmacy Times spoke with Angela Kashuba, Dean of UNC Eshelman School of Pharmacy and Patrick Brown, UNC Eshelman School of Pharmacy Alumni, about preparation for the possibility of a general public COVID-19 vaccine.

Moderna intends to submit the EUA application today and believes that the FDA’s Vaccines and Related Biological Products Advisory Committee will meet to review the safety and efficacy data package on Thursday, December 17, according to the press release.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.